RUZURGI (amifampridine) - Authorization Status
Why it was recalled
New safety information - Product withdrawal
Other Recent Recalls
Apo-Semaglutide Injection
Apo-Semaglutide Injection : Incorrect dose display
Type II2026-09-24
Moderate health risk
Novo-Gesic Forte 500 mg tablets (acetaminophen)
Generic acetaminophen by Teva recalled because it may contain foreign material
Type I2026-09-10
Highest health risk
JAMP Temozolomide
JAMP Temozolomide: Out-of-Specification (Assay)
Type II2026-08-31
Moderate health risk
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.